Type 2 diabetes is a major burden on systems in the entire world. It is especially prevalent among older men, who typically don’t follow healthy diets, don’t exercise and generally don’t take good care of themselves. Now a team of scientists led by the University of Adelaide found that two years of testosterone might help...
Researchers suggested that baldness should be considered a risk factor, dubbing it the ‘Gabrin sign’ By Jennifer Rigby 4 June 2020 • 8:33pm Bald men may be at higher risk of suffering from severe Covid-19 symptoms, emerging evidence suggests. The link is so strong that some researchers are suggesting baldness should be considered a risk...
WOLTERS KLUWER HEALTH For the many men diagnosed with testosterone deficiency, losing weight can help increase testosterone levels. But certain diets – specifically a low-fat diet – may be associated with a small but significant reduction in testosterone, suggests a study in The Journal of Urology®, Official Journal of the American Urological Association (AUA). The...
by University of Southern California USC researchers have successfully grown human, testosterone-producing cells in the lab, paving the way to someday treat low testosterone with personalized replacement cells. In today’s Proceedings from the National Academy of Sciences, scientists describe how they transformed stem cells into functioning Leydig cells—the cells in the testes that produce the...
by University of Texas Medical Branch at Galveston Long-term opioid use previously has been linked with low testosterone in men. What has been unclear is how many men taking opioids had been screened or treated for low testosterone. A new study by researchers from The University of Texas Medical Branch at Galveston has found a...
by University of Southern California Men who want to improve their libido or build body mass may want to think twice before using testosterone-boosting supplements—also known as “T boosters—as research shows these alternatives to traditional testosterone replacement therapy may not have ingredients to support their claims, according to Mary K. Samplaski, MD, assistant professor of clinical...
DANA-FARBER CANCER INSTITUTE After 3 years, 80% of men with metastatic hormone-sensitive prostate cancer who received enzalutamide along with testosterone suppression were alive compared to 72% of men who received standard care. Chicago – Enzalutamide, an oral androgen receptor inhibitor, can improve outcomes for men with metastatic hormone-sensitive prostate cancer (mHSPC), according to a large study presented by Christopher Sweeney, MBBS of Dana-Farber Cancer Institute’s Lank Center for...
Recent studies suggest that long-term sufferers of Cachexia may be in for some much needed good news. Experienced by as many as half of all cancer patients – and responsible for the deaths of around 22% – Cachexia may have met its match with new technologies on the horizon already proving successful in minimizing its energy-sapping...
(HealthDay)—Jatenzo (testosterone undecanoate) has been approved by the U.S. Food and Drug Administration to treat men with low testosterone, medically called hypogonadism. The approval covers men with low levels of the male hormone due to specific medical conditions, including genetic disorders such as Klinefelter syndrome or tumors that have damaged the pituitary gland, the agency said in a news release. Jatenzo should not be used to treat men with “age-related...
Scientists at the University of Virginia and elsewhere have mapped out how the body transports testosterone, and their surprising findings may explain low testosterone levels seen in men with diabetes or patients on certain medications. The discovery allows scientists to understand exactly how testosterone, the male sex hormone, binds to a protein called serum albumin...
